PDF) Inflammatory vaginitis in women on long-term rituximab treatment for autoimmune disorders
Rituximab in MS | Experimental MS Treatments | Multiple Sclerosis News Today
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial - The Lancet
PV | RITUXAN® (rituximab) Safety Data
The importance of continuing with RITUXAN® (rituximab) for RA Patients
effects of rituximab in the patient described in this case report... | Download Scientific Diagram
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial - The Lancet
RA | Safety Data & Possible Side Effects | RITUXAN® (rituximab)
Both the rituximab dose and maintenance immunosuppression in steroid-dependent/frequently-relapsing nephrotic syndrome have important effects on outcomes - ScienceDirect
Frontiers | Past, Present, and Future of Rituximab—The World's First Oncology Monoclonal Antibody Therapy
GPA & MPA | RITUXAN® (rituximab) Safety on Follow Up Treatment
Rituximab Treatment in Nephrotic Syndrome ESPN ppt download
Effect of Immunosuppressive Diseases and Rituximab Infusions on Allowing COVID-19 Infection to Relapse | The Permanente Journal
Rituximab - Wikipedia
Frontiers | Rituximab Therapy for Primary Sjögren's Syndrome
Use of rituximab in paediatric nephrology | Archives of Disease in Childhood
Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective | Critical Care | Full Text
RA | Safety Data & Possible Side Effects | RITUXAN® (rituximab)
GVHD in pediatric HSCT patients: Clinical trials for Rituximab - Oncology Nurse Advisor
Frontiers | Past, Present, and Future of Rituximab—The World's First Oncology Monoclonal Antibody Therapy
Rituximab-induced lung disease: a systematic literature review | European Respiratory Society
Rituximab therapy in nephrotic syndrome: implications for patients' management | Nature Reviews Nephrology
